Epidemiology of Lung Cancer
2 EPIDEMIOLOGY OF LUNG CANCER Goetz Kloecker, MD, MBA, MSPH, FACP You are director of the World Health Organization and ask your global experts which cancer should receive the most…
Staging of Lung Cancer
12 STAGING OF LUNG CANCER Susanne M. Arnold, MD A 48-year-old female presents to her primary care physician with a 2-month history of shortness of breath. Chest radiographs reveal a…
Pathobiology of Non–Small Cell Lung Carcinoma
6 PATHOBIOLOGY OF NON–SMALL CELL LUNG CARCINOMA Mostafa M. Fraig, MD, MBA A 60–year-old Asian female had a 4-cm lung mass biopsied by core needle biopsy. She never smoked and…
Pathobiology of Small Cell Carcinoma and Other Neuroendocrine Tumors of the Lung
7 PATHOBIOLOGY OF SMALL CELL CARCINOMA AND OTHER NEUROENDOCRINE TUMORS OF THE LUNG Mostafa M. Fraig, MD, MBA A 60-year-old white male had a 6-cm central lung mass biopsied by…
Interventional Radiology in the Diagnosis and Treatment of Lung Cancer
Related posts: Prevention of Lung Cancer History of Lung Cancer Malignant Pleural Mesothelioma Thymic Cancer Tobacco and Lung Cancer Diagnostics of Lung Cancer
Malignant Pleural Mesothelioma
23 MALIGNANT PLEURAL MESOTHELIOMA Hamza Hashmi, MD A 70-year-old white man with past medical history of hypertension (HTN) and chronic obstructive pulmonary disease (COPD) presents with a persistent cough for…
Small Cell Lung Cancer Treatment: Early Stage
16 SMALL CELL LUNG CANCER TREATMENT: EARLY STAGE Victor van Berkel, MD, PhD • Neal E. Dunlap, MD • Matthew Fox, MD • Alden Klarer, MD, PhD • Kate Alyse…
Pulmonary Carcinoid
22 PULMONARY CARCINOID Hamza Hashmi, MD A 65-year-old white man with a past medical history of hypertension (HTN) and chronic obstructive pulmonary disease (COPD) presents with persistent cough for the…
Economics of Lung Cancer
Related posts: Prevention of Lung Cancer History of Lung Cancer Malignant Pleural Mesothelioma Thymic Cancer Tobacco and Lung Cancer Diagnostics of Lung Cancer
Immunotoxicity
21 IMMUNOTOXICITY Amitoj Gill, MD • Rahul Gosain, MD This case involves a 68-year-old man diagnosed with metastatic non–small cell lung cancer (NSCLC) and adenocarcinoma histology with a programmed death…
